Email Michael Daniels

NASDAQ:SRPT Shareholder Notice: Investigation over Potential Securities Laws Violations by Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc is under investigation over potential securities laws in connection with certain financial statements.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy